Skip to main content
. Author manuscript; available in PMC: 2016 Nov 1.
Published in final edited form as: Hippocampus. 2015 May 2;25(11):1429–1446. doi: 10.1002/hipo.22464

Figure 3. Fluoxetine treatment decreases the basal expression of activity marker c-fos in DG and CA3 in adulthood and middle age.

Figure 3

A. Representative cfos immunostained coronal sections of dorsal and ventral DG and CA3 in adult and middle aged mice taken from home cage. Fluoxetine treatment 18mg/kg/day for 28 days. B. Quantification of c-fos positive cells. Adult n=3 (VEH), 5 (FLX) mice per group, dDG p=0.0008, vDG p=0.0326, dCA3 p=0.0055, vCA3 p=0.0067; middle-aged n=3 (VEH), 4 (FLX), dDG p=0.0009, vDG p=0.0552, dCA3 p=0.0052, vCA3 p=0.1973). Results are expressed as mean (±SEM). *, P<0.05; **, P<0.01; *** P<0.001. Scale bar 100μM.